About: Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • We investigated whether alpha-TOS and several novel vitamin E analogs kill breast cancer cells overexpressing the antiapoptotic receptor protein HER2/erbB2. The agents induced apoptosis at comparable levels in both erbB2-low and -high cells. Generation of ROS preceded mitochondrial destabilization and execution of apoptosis. Dissipation of DeltaPsi(m) was followed by cytochrome c and Smac/Diablo re-localization and caspase-dependent cleavage of death substrate. A resistance to apoptosis for the corresponding rho(0) counterparts confirmed a critical dependency for mitochondria during the induction of apoptosis in breast cancer cells mediated by VE analogs and linked apoptosis to generation of radicals. alpha-TOS thus causes efficient apoptosis in breast cancer cells independent of their erbB2 status. Since erbB2 is frequently over-expressed in breast cancers and renders the neoplastic disease resistant to established treatment, our findings are of clinical interest.
  • We investigated whether alpha-TOS and several novel vitamin E analogs kill breast cancer cells overexpressing the antiapoptotic receptor protein HER2/erbB2. The agents induced apoptosis at comparable levels in both erbB2-low and -high cells. Generation of ROS preceded mitochondrial destabilization and execution of apoptosis. Dissipation of DeltaPsi(m) was followed by cytochrome c and Smac/Diablo re-localization and caspase-dependent cleavage of death substrate. A resistance to apoptosis for the corresponding rho(0) counterparts confirmed a critical dependency for mitochondria during the induction of apoptosis in breast cancer cells mediated by VE analogs and linked apoptosis to generation of radicals. alpha-TOS thus causes efficient apoptosis in breast cancer cells independent of their erbB2 status. Since erbB2 is frequently over-expressed in breast cancers and renders the neoplastic disease resistant to established treatment, our findings are of clinical interest. (en)
  • Zkoumali jsme, zda alfa-TOS a řada nových analogů vitamínu E zabíjí buňky nádoru prsu se zvýšenou expresí antiapoptotického receptorového proteinu HER2/erbB2. Zkoumané látky vyvolávaly apoptózu na srovnatelné úrovni u buněk s nízkou i vysokou hladinou erbB2. Před destabilizací mitochondrií a spuštěním apoptózy docházelo k tvorbě ROS. Ztrátu potenciálu delta-psí(m) následovala relokalizace cytochromu c a Smac/Diablo a také štěpení substrátu buněčné smrti závislé na kaspázách. Odolnost vůči apoptóze u odpovídajících protějšků rho(0) potvrdila kritickou závislost na mitochondriích během indukce apoptózy v buňkách nádoru prsu vyvolanou analogy VE a propojila apoptózu s tvorbou radikálů. Alfa-TOS tedy vyvolává účinnou apoptózu u buněk nádoru prsu nezávisle na jejich expresi erbB2. Jelikož exprese erbB2 je u nádoru prsu často zvýšena a vyvolává u neoplázií odolnost vůči zavedené léčbě, naše poznatky mají klinický význam. (cs)
Title
  • Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway
  • Analogy vitamínu E vyvolávají apoptózu v buňkách nádoru prsu se zvýšenou expresí HER2/erbB2 signalizací mitochondriální dráhou (cs)
  • Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway (en)
skos:prefLabel
  • Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway
  • Analogy vitamínu E vyvolávají apoptózu v buňkách nádoru prsu se zvýšenou expresí HER2/erbB2 signalizací mitochondriální dráhou (cs)
  • Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway (en)
skos:notation
  • RIV/68378050:_____/05:00001362!RIV06-AV0-68378050
http://linked.open.../vavai/riv/strany
  • 282;289
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • Z(AV0Z5052915)
http://linked.open...iv/cisloPeriodika
  • 4
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 548951
http://linked.open...ai/riv/idVysledku
  • RIV/68378050:_____/05:00001362
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • vitamin E analogs; apoptosis; ErbB2 (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [B5563FE9DE19]
http://linked.open...i/riv/nazevZdroje
  • Biochemical and Biophysical Research Communications
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 326
http://linked.open...iv/tvurceVysledku
  • Neužil, Jiří
  • Salvatore, B. A.
  • Witting, P. K.
  • Wang, X.-F.
http://linked.open...n/vavai/riv/zamer
issn
  • 0006-291X
number of pages
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 77 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software